gip and glp-1 agonist The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes Possible mechanisms of action of

Application: 1) Enhances physical performance and reduces muscle soreness in sports nutrition products

10.1016/j.neuint.2012.04.008 36

Published studies have investigated GHK-Cu in tissue remodelling, skin physiology, wound healing, connective tissue biology, angiogenesis, inflammatory signalling, hair biology and regenerative medicine

Adverse reactions: Any adverse reactions to the Depo-Provera injection must be documented, including the nature and severity of the reaction and any treatment provided

Coverage also includes therapy services aimed at supporting recovery

If an allergic reaction occurs, discontinue use and seek medical attention immediately